Male and female ecstasy users: Differences in patterns of use, sleep quality and mental health outcomes

Drug and Alcohol Dependence

Volumn 132, Issue 1-2, 2013, Pages 223-230

  Ogeil, Rowan P ^a   Rajaratnam, Shantha M W ^a   Broadbear, Jillian H ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Ecstasy; MDMA; Polydrug use; Sex differences; Sleep

Indexed keywords

ADULT; ARTICLE; AUSTRALIA; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DRUG DEPENDENCE; DRUG USE; EMOTION; EPWORTH SLEEPINESS SCALE; FEMALE; GUILT; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; MOOD CHANGE; MULTIPLE DRUG ABUSE; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; PRIORITY JOURNAL; QUESTIONNAIRE; SEX DIFFERENCE; SHORT FORM 12; SLEEP DISORDER; SLEEP QUALITY; UNITED STATES;

ECSTASY; MDMA; POLYDRUG USE; SEX DIFFERENCES; SLEEP;

ADULT; AFFECT; AMPHETAMINE-RELATED DISORDERS; FEMALE; GUILT; HALLUCINOGENS; HUMANS; MALE; MENTAL HEALTH; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; QUESTIONNAIRES; RECURRENCE; REGRESSION ANALYSIS; SEX CHARACTERISTICS; SLEEP; SLEEP DISORDERS; SUBSTANCE-RELATED DISORDERS; YOUNG ADULT;

EID: 84881662035     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2013.02.002     Document Type: Article

References (76)

1. Alexander D. A marijuana screening inventory (experimental version): description and preliminary psychometric properties. Am. J. Drug Alcohol Abuse 2003, 29:619-646.
2. Allott K., Redman J. Are there sex differences associated with the effects of ecstasy/3,4-methylenedioxymethamphetamine (MDMA)?. Neurosci. Biobehav. Rev. 2007, 31:327-347.
3. Attali G., Weizman A., Gil-Ad I., Rehavi M. Opposite modulatory effects of ovarian hormones on rat brain dopamine and serotonin transporters. Brain Res. 1997, 756:153-159.
4. Babor T.F., Higgins-Biddle J.C., Saunders J.B., Monteiro M.G. The Alcohol Use Disorders Identification Test: Guidelines for Use in Primary Care 2001, World Health Organization, Switzerland. 2nd ed.
5. Becker J.B., Arnold A.P., Berkley K.J., Blaustein J.D., Eckel L.A., Hampson E., Herman J.P., Marts S., Sadee W., Steiner M., Taylor J., Young E. Strategies and methods for research on sex differences in brain and behavior. Endocrinology 2005, 146:1650-1673.
6. Bedi G., Redman J. Self-reported ecstasy use: the impact of assessment method on dosage estimates in recreational users. J. Psychopharmacol. 2006, 20:432-436.
7. Bolla K.I., McCann U.D., Ricaurte G.A. Memory impairment in abstinent MDMA ("Ecstasy") users. Neurology 1998, 51:1532-1537.
8. Broadbear J.H., Nguyen T., Clarke I.J., Canny B.J. Antidepressants, sex steroids and pituitary - adrenal response in sheep. Psychopharmacology (Berl) 2004, 175:247-255.
9. Bruno R., Matthews A.J., Dunn M., Alati R., McIllwraith F., Hickey S., Burns L., Sindicich N. Emerging psychoactive substance use among regular ecstasy users in Australia. Drug Alcohol Depend. 2012, 124:19-25.
10. Bubar M.J., Thomas M.L., Cunnigham K.A. Effects of acute (+)-3,4-methylenedioxymethamphetamine [(+)-MDMA] on locomotor activity in male and female rats. Drug Alcohol Depend. 2001, 63:S20-S21.
11. Bubenakova V., Votava M., Horacek J., Palenacek T. Relation of sex and estrous phase to deficits in prepulse inhibition of the startle response induced by ecstasy (MDMA). Behav. Pharmacol. 2005, 16:127-130.
12. Buysse D.J., Reynolds I.C.F., Monk T.H., Berman S.R., Kupfer D.J. The pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989, 28:193-213.
13. Carhart-Harris R.L., Nutt D.J., Munafo M., Wilson S.J. Current and former ecstasy users report different sleep to matched controls: a web-based questionnaire study. J. Psychopharmacol. 2009, 23:249-257.
14. Carlsson M., Carlsson A. A regional study of sex differences in rat brain serotonin. Prog. Neuropsychopharmacol. Biol. Psychiatry 1988, 12:53-61.
15. Carney C., Segal Z., Edinger J., Krystal A. A comparison of rates of residual insomnia symptoms following pharmacotherapy or cognitive-behavioral therapy for major depressive disorder. J. Clin. Psychiatry 2007, 68:254-260.
16. Cosgrove K.P., Mazure C.M., Staley J.K. Evolving knowledge of sex differences in brain structure, function, and chemistry. Biol. Psychiatry 2007, 62:847-855.
17. Curran H.V., Travill R.A. Mood and cognitive effects of +3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy'): week-end 'high' followed by mid-week low. Addiction 1997, 92:821-831.
18. Durmer J., Dinges D. Neurocognitive consequences of sleep deprivation. Semin. Neurol. 2005, 25:117-129.
19. Elmenhorst D., Elmenhorst E.-M., Luks N., Maass H., Mueller E.-W., Vejvoda M., Wenzel J., Samel A. Performance impairment during four days partial sleep deprivation compared with the acute effects of alcohol and hypoxia. Sleep Med. 2009, 10:189-197.
20. Evans S., Haney M., Foltin R. The effects of smoked cocaine during the follicular and luteal phases of the menstrual cycle in women. Psychopharmacology (Berl) 2002, 159:397-406.
21. Festa E.D., Russo S.J., Gazi F.M., Niyomchai T., Kemen L.M., Lin S.-N., Foltz R., Jenab S., Quinones-Jenab V. Sex differences in cocaine-induced behavioral responses, pharmacokinetics, and monoamine levels. Neuropharmacology 2004, 46:672-687.
22. Fox H.C., Parrott A.C., Turner J.J.D. Ecstasy use: cognitive deficits related to dosage rather than self-reported problematic use of the drug. J. Psychopharmacol. 2001, 15:273-281.
23. Gouzoulis-Mayfrank E., Daumann J. The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview. Psychopharmacology (Berl) 2006, 20:188-193.
24. Green A., Gabrielsson J., Marsden C., Fone K. MDMA: on the translation from rodent to human dosing. Psychopharmacology (Berl) 2009, 204:375-378.
25. Holmila M., Raitasalo K. Gender differences in drinking: why do they still exist?. Addiction 2005, 100:1763-1769.
26. Johns M.W. A new method for measuring daytime sleepiness: the epworth sleepiness scale. Sleep 1991, 14:540-545.
27. Johns M.W. Reliability and factor analysis of the epworth sleepiness scale. Sleep 1992, 15:376-381.
28. Justice A.J.H., De Wit H. Acute effects of d-amphetamine during the early and late follicular phases of the menstrual cycle in women. Pharmacol. Biochem. Behav. 2000, 66:509-515.
29. Kaasinen V., Nagren K., Hietala J., Farde L., Rinne J.O. Sex differences in extrastriatal eopamine D2-like receptors in the human brain. Am. J. Psychiat. 2001, 158:308-311.
30. Koenig J., Lazarus C., Jeltsch H., Hamida S.B., Riegert C., Kelche C., et al. MDMA (ecstasy) effects in pubescent rats: males are more sensitive than females. Pharmacol. Biochem. Behav. 2005, 81:635-644.
31. Lavalaye J., Booij J., Reneman L., Habraken J.B.A., van Royen E.A. Effect of age and gender on dopamine transporter imaging with [123I]FP-CIT SPET in healthy volunteers. Eur J Nucl. Med. Mol. Imag. 2000, 27:867-869.
32. Liechti M.E., Gamma A., Vollenweider F.X. Gender differences in the subjective effects of MDMA. Psychopharmacology 2001, 154:161-168.
33. Liechti M.E., Saur M.R., Gamma A., Hell D., Vollenweider F.X. Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5-HT2 antagonist ketanserin in healthy humans. Neuropsychopharmacology 2000, 23:396-404.
34. Lynch W., Roth M., Carroll M. Biological basis of sex differences in drug abuse: preclinical and clinical studies. Psychopharmacology 2002, 164:121-137.
35. McCann U.D., Wilson M.J., Sgambati F.P., Ricaurte G.A. Sleep deprivation differentially impairs cognitive performance in abstinent methylenedioxymethamphetamine ("Ecstasy") users. J. Neurosci. 2009, 29:14050-14056.
36. Milani R.M., Parrott A.C., Turner J.J.D., Fox H.C. Gender differences in self-reported anxiety, depression, and somatization among ecstasy/MDMA polydrug users, alcohol/tobacco users, and nondrug users. Addict. Behav. 2004, 29:965-971.
37. Miyata S., Noda A., Ozaki N., Hara Y., Minoshima M., Iwamoto K., et al. Insufficient sleep impairs driving performance and cognitive function. Neurosci. Lett. 2010, 469:229-233.
38. Moon D.G., Hecht M.L., Jackson K.M., Spellers R.E. Ethnic and gender differences and similarities in adolescent drug use and refusals of drug offers. Subst. Use Misuse 1999, 34:1059-1083.
39. Murphy P.N., Wareing M., Fisk J.E. Users' perceptions of the risks and effects of taking ecstasy (MDMA): a questionnaire study. J. Psychopharmacol. 2006, 20:447-455.
40. Ogeil R.P., Rajaratnam S.M.W., Broadbear J.H. Ecstasy and sleep disturbance: progress towards elucidating a tole for the circadian system. Sleep Biol. Rhythm 2012, 10:3-13.
41. Ogeil R.P., Rajaratnam S.M.W., Broadbear J.H. Disturbed sleep in ecstasy users reported by partners/roommates. Aust. NZ J. Psychiat. 2012, 46:587-588.
42. Ogeil R.P., Rajaratnam S.M.W., Phillips J.G., Redman J.R., Broadbear J.H. Ecstasy use and self-reported disturbances in sleep. Hum. Psychopharmacol. 2011, 26:508-516.
43. O'Hearn E., Battaglia G., De Souza E.B., Kuhar M.J., Molliver M.E. Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity. J. Neurosci. 1988, 8:2788-2803.
44. Palenicek T., Votava M., Bubenikova V., Horacek J. Increased sensitivity to the acute effects of MDMA ("ecstasy") in female rats. Physiol. Behav. 2005, 86:546-553.
45. Parrott A.C. Chronic tolerance to recreational MDMA (3,4-methylenedioxymethamphetamine) or ecstasy. J. Psychopharmacol. 2005, 19:71-83.
46. Parrott A.C. Human psychopharmacology of Ecstasy (MDMA): a review of 15 years of empirical research. Hum. Psychopharmacol. 2001, 16:557-577.
47. Parrott A.C., Lasky J. Ecstasy (MDMA) effects upon mood and cognition: before, during and after a saturday night dance. Psychopharmacology (Berl) 1998, 139:261-268.
48. Parrott A.C., Rodgers J., Buchanan T., Ling J., Heffernan T.M., Scholey A.B. Dancing hot on ecstasy: physical activity and thermal comfort ratings are associated with the memory and other psychobiological problems reported by recreational MDMA users. Hum. Psychopharmacol. 2006, 21:285-298.
49. Parsons J.T., Kelly B.C., Wells B.E. Differences in club drug use between heterosexual and lesbian/bisexual females. Addict. Behav. 2006, 31:2344-2349.
50. Pirona A., Morgan M.J. An investigation of the subacute effects of ecstasy on neuropsychological performance, sleep and mood in regular ecstasy users. J. Psychopharmacol. 2010, 24:175-185.
51. Randall S., Johanson C.E., Tancer M., Roehrs T. Effects of acute 3,4-methylenedioxymethamphetamine on sleep and daytime sleepiness in MDMA users: a preliminary study. Sleep 2009, 32:1513-1519.
52. Rendell P.G., Gray T.J., Henry J.D., Tolan A. Prospective memory impairment in "ecstasy" (MDMA) users. Psychopharmacology (Berl) 2007, 194:497-504.
53. Ricaurte G.A., Martello A.L., Katz J.L., Martello M.B. Long lasting effects of +/-methylenedioxymethamphetamine (MDMA) on central serotonergic neurons in nonhuman primates: neurochemical observations. J. Pharmacol. Exp. Ther. 1992, 261:616-622.
54. Rodgers J., Buchanan T., Scholey A.B., Heffernan T.M., Ling J., Parrott A.C. Differential effects of ecstasy and cannabis on self-reports of memory ability: a web-based study. Hum. Psychopharmacol. 2001, 16:619-625.
55. Rodgers J., Buchanan T., Scholey A.B., Heffernan T.M., Ling J., Parrott A.C. Patterns of drug use and the influence of gender on self-reports of memory ability in ecstasy users: a web-based study. J. Psychopharmacol. 2003, 17:389-396.
56. Sanderson K., Andrews G. The SF-12 in the Australian population: cross-validation of item selection. Aust. NZ J. Pub. Health 2007, 26:343-345.
57. Scholey A.B., Owen L., Gates J., Rodgers J., Buchanan T., Ling J., Heffernan T., Swan P., Stough C., Parrott A.C. Hair MDMA samples are consistent with reported ecstasy use: findings from a study investigating effects of ecstasy on mood and memory. Neuropsychobiology 2011, 63:15-21.
58. Sell S.L., Scalzitii J.M., Thomas M.L., Cunnigham K.A. Influence of ovarian hormones and estrous cycle on the behavioral response to cocaine in female rats. J. Pharmacol. Exp. Ther. 2000, 293:879-886.
59. Sindicich, N., Burns, L., Stafford, J., George, F., Kong, F., Matthews, A. et al., 2009. Australian Trends in Ecstasy and related drugs markets 2008: Findings from the Ecstasy and Related Drugs Reportign System (EDRS) Australian Drug Trends Series No. 28: National Drug and Alcohol Research Centre, University of New South Wales.
60. Spanagel R., Rosenwasser A.M., Schumann G., Sarkar D.K. Alcohol consumption and the body's biological clock. Alcohol. Clin. Exp. Res. 2005, 29:1550-1557.
61. 123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers. Synapse 2001, 41:275-284.
62. Staner L. Comorbidity of insomnia and depression. Sleep Med. Rev. 2010, 14:35-46.
63. Sumner B.E.H., Fink G. Estrogen increases the density of 5-hydroxytryptamine(2A) receptors in cerebral cortex and nucleus accumbens in the female rat. J. Steroid Biochem. Mol. Biol. 1995, 54:15-20.
64. Ter Bogt T.F.M., Engels R.C.M.E. Partying hard: party style, motives for and effects of MDMA use at rave parties. Subst. Use Misuse 2005, 40:1479-1502.
65. Ursin R. Serotonin and sleep. Sleep Med. Rev. 2002, 6:55-67.
66. Van Dongen H.P.A., Maislin G., Mullington J.M., Dinges D.F. The cumulative cost of additional wakefulness: dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation. Sleep 2003, 26:117-126.
67. Verheyden S.L., Hadfield J., Calin T., Curran H.V. Sub-acute effects of MDMA (+\- 3,4-methylenedioxymethamphetamine, "ecstasy") on mood: evidence of gender differences. Psychopharmacology (Berl) 2002, 161:23-31.
68. Voderholzer U., Al-Shajlaw A., Weske G., Feige B., Riemann D. Are there gender differences in objective and subjective sleep measures? A study of insomniacs and health controls. Depress. Anxiety 2003, 17:162-172.
69. von Sydow K., Lieb R., Pfister H., Höfler M., Wittchen H.-U. Use, abuse and dependence of ecstasy and related drugs in adolescents and young adults - a transient phenomenon? Results from a longitudinal community study. Drug Alcohol Depend. 2002, 66:147-159.
70. Weissman M.M., Greenwald S., Niño-Murcia G., Dement W.C. The morbidity of insomnia uncomplicated by psychiatric disorders. Gen. Hospital Psychiat. 1997, 19:245-250.
71. White T.L., Justice A.J.H., de Wit H. Differential subjective effects of -amphetamine by gender, hormone levels and menstrual cycle phase. Pharmacol. Biochem. Behav. 2002, 73:729-741.
72. Wirz-Justice A. Biological rhythm disturbances in mood disorders. Int. Clin. Psychopharmacol. 2006, 21:S11-S15.
73. Wirz-Justice A., Van den Hoofdakker R.H. Sleep deprivation in depression: what do we know, where do we go?. Biol. Psychiat. 1999, 46:445-453.
74. Zhang L., Ma W., Barker J.L., Rubinow D.R. Sex differences in expression of serotonin receptors (subtypes 1A and 2A) in rat brain: a possible role of testosterone. Neuroscience 1999, 94:251-259.
75. Zhou W., Cunningham K.A., Thomas M.L. Estrogen regulation of gene expression in the brain: a possible mechanism altering the response to psychostimulants in female rats. Mol. Brain Res. 2002, 100:75-83.
76. Zhou W., Cunnigham K.A., Thomas M.L. Estrogen effects on the hyperactivity induced by (+)-MDMA and cocaine in female rats. Behav. Neurosci. 2003, 117:84-94.